Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
This process includes extensive molecular simulations of the receptor in its native membrane environment, along with ensemble virtual screening that accounts for its conformational mobility. In the case of dimeric or oligomeric receptors, the entire functional complex is modelled, identifying potential binding pockets on and between the subunits to encompass all possible mechanisms of action.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P49286
UPID:
MTR1B_HUMAN
Alternative names:
-
Alternative UPACC:
P49286
Background:
The Melatonin receptor type 1B, encoded by the gene symbol P49286, plays a pivotal role in the human body by serving as a high affinity receptor for melatonin. This receptor is instrumental in mediating the reproductive and circadian actions of melatonin, functioning through G proteins that inhibit adenylate cyclase activity.
Therapeutic significance:
Understanding the role of Melatonin receptor type 1B could open doors to potential therapeutic strategies. Its involvement in regulating circadian rhythms and reproductive functions highlights its potential as a target for treating related disorders.